N15-Isothiouronium derivatives of teicoplanin and its aglycone submitted to alkaline condition give rise to an intramolecular cyclization. The structures of the new f-lactam derivatives were determined by using *H NMR,IR and fast atom bombardment mass spectra. The cyclization mechanism was interpreted on the basis of the identification of the intermediate structure. The poor in vitro antibacterial activity of the new cyclic compounds and the negligible affinity for the synthetic peptidoglycan model Ac2-L-Lys-D-Ala-D-Ala is probably due to the lack of the N-17 amidic proton and to the lack of the basic character of the nitrogen in position15.
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Teicoplanin (Targocid) is a new glycopeptide antibiotic13 recently introduced in some countries for the treatment of severe Gram-positive bacterial infections.23
Teicoplanin (CTA) consists ( Fig. 1 ) of five major closely related factors (A2/l~5) differing in the TV-acyl chain linked with /3-D-glucosamine at position C-56. CTAalso contains one a-D-mannose and one JV-acetyl-a-D-glucosamine at C-42 and C-34 positions, respectively.13 All three sugars can be removed by acidic hydrolysis under selected conditions obtaining the related aglycone (TD) (Fig.   I ).33
In a program of synthetic modification directed to extend the antibacterial activity of CTAand TD against Gram-negative bacteria, it was considered of interest to introduce the guanidine group into the structure of the above compoundsto verify if the positively charged guanidine derivatives can penetrate the cell-wall of Gram-negative microorganisms better than the parent compound. In the literature are reported several natural antibiotics containing a guanidine unit (pK=13.6y) showing some activity against Gram-negative bacteria. Streptomycin53 is the best example of a guanidine carrying antibiotic active against Gram-negative bacteria.
Chemistry
Thedisplacement of methylmercaptanefrom an isothiouronium salt is a well-knownmethodfor preparing guanidine.63 Therefore, some previously described73 isothiouronium derivatives of CTA and TD(I, Scheme 1) were selected for their transformation into differently substituted guanidine derivatives (II). Surprisingly, by utilizing different primary amines, instead of the expected compounds II, compoundsIV, carrying a f-lactam ring between C-15 and C-16, were obtained. The new structures were determined by XHNMR,IR and fast atom bombardment mass spectra (FAB-MS) spectroscopies.
By reaction of isothiouronium derivatives of TD, for example Ic, with primary amines (methylamine and ethylenediamine) in MeOHthe formation of two peaks, IIIc and IVc, were detected by Fig. 2) and by heating up to 40°C a rapid transformation of IIIc into IVc was obtained. The formation of the two peaks was independent of the amine used. The same result was obtained using triethylamine (TEA) in MeOH.When the reaction was carried out in CH3CN-H2O-TEAonly peak IIIc formed. This compound was isolated and quantitatively transformed into peak IVc by dissolution in MeOHat 40°C.
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Starting from Id the corresponding intermediate compound Hid was also isolated. Compounds IV, obtained from the corresponding CTA or TD derivatives (la~Ig), showed a decreased solubility in acidic water as compared with that of the starting antibiotics, as expected due to the reduced basicity of C(15)-N.
Structure Determination
The IR spectra of compounds IVa~IVg showed an absorption in the range of 173O~1740 cm"1, attributable to the C=O stretching of a?--lactam ring. The frequency is higher by 10~20 cm"1 than a five membercyclic urea and is due to the electron withdrawing character of the exo-cyclic double bond C(16)=N(17).
FAB-MSspectrometry shows the MW'sof the synthesized compounds (Table 1) dance with the proposed structure.
The selected XHNMRspectral attributions, reported in Table 2 , were based on the comparison with data for teicoplanin and other glycopeptides,3) on selective decoupling and 2D correlation spectroscopy (COSY) experiments. The structure of compounds IV is well characterized by their 2H NMRspectra in comparison with parent compounds. In particular, the cyclic ureide linked to C-15 and C-16 is evidenced by the disappearance of 1 7-H signal, which was involved in the isoamidic equilibrium N(1 7)H-C(1 6)O*-*N(1 7> C(16)OH necessary for the ring closure, and the significant change in chemical shifts of the protons a Recorded in DMSO-d6solution with TMSas internal reference (50.00) with a 250MHzBruker spectrometer equipped with an Aspect 3000 computer, nd: Not determined. from 15-H to 27-H. This variation is interpreted as being due to the insertion ofa ONand a new ring into the core of the molecule, a fact which causes a steric rearrangement involving various anisotropic effects.
The formation of IV can be explained with the formation under alkaline conditions of the base of isothiourea (I), less stable than the corresponding salt, followed by the nucleophilic displacement of CompoundsHid and IVa~IVg were assayed for antibacterial activity against selected microorganisms. All the compoundstested show a negligible activity on Gram-positive with MICsten times or higher than the reference compoundsCTAand TD (Table 3) , while they result to be inactive against the Gram-negative bacteria. CompoundIIIc was tested because of the general poor activity of these cyclic derivatives.
Binding Studies
The binding strengths (KA) to the synthetic peptidoglycan analogue Ac2-L-Lys-D-Ala-D-Ala of compounds Hid and IVa -' IVg were measured by UVdifferential spectroscopy.12) The experiments were run in phosphate buffer at pH 9 due to the insolubility of the compounds in the generally used citric buffer at pH 5. All the measurements indicated a weak binding strength (KA <103).
Conclusion
The isothiouronium salts of CTAand TD(I) undergo an intramolecular cyclization in the presence of amines instead of giving the expected guanidine derivatives II (Scheme 1). The pathway of this reaction, producing a f-lactam ring between position 15 and 16 (IV) of parent antibiotics, has also been verified with the isolation and identification of the oxazoline intermediate (IIIc and Hid). The newstructures Hid and IVa~IVgshow a low affinity constant for Ac2-L-Lys-D-Ala-D-Alaand a negligible activity against Gram-positive bacteria, as a predictable consequence of the modifications, i.e., the absence of the protonable C(15)-N amino group and the loss of N-17 proton. This latter seems to be essential in participating in the complex formation with the terminal carboxyl group of the muramylpentapeptide. 10)
Experimental
Evaporation of solvents was carried out, after adding BuOHto prevent foaming, with a rotary evaporator at 45°C under vacuum. If not otherwise stated, the intermediates and the final products were washed with Et2O and dried at 50°C under vacuum.
Products were purified by reversed-phase column chromatography on silanized silica gel (0.0630 .2 mm, Merck) by eluting with a linear gradient of CH3CNin water.
Monitoring of the reactions and the chromatographic fractions and control of the purity of the compounds was done by HPLCwith a chromatograph Hewlett-Packard 1090L equipped with a UV detector at 254 nm and a column ODS-Hypersil (C-18) 5 jam, 100 x4.6 mm.
Injection volume UVDifference Spectroscopy Binding constants between peptide and compounds were measured essentially as described by Nieto and Perkins13) except that the tandem arrangement of cells was not required since the peptide used had no significant absorption in the range 260~340 nm.
Experiments were carried out with a Perkin-Elmer model 320 spectrophotometer. Cells with 4 cm light-path filled with 10 ml of solutions containing antibiotic (35 x 1O~6 m in 0.02 m Na2HPO4, pH 9) were placed in the sample and reference compartments and the difference in absorbance, occurring upon the addition of Ac2-L-Lys-D-Ala-D-Ala (10^50^1 of a 4-mMsolution) to the sample cell and the same volume of buffer to the reference cell, was measured as 285~290 nm. Association constants were determined by Scatchard plot analysis.
Microbiological Assay MICwas determined using the 2-fold dilution methodin microtiter system. The media used were : Todd-Hewitt broth (Difco) for Streptococci and Iso-Sensitest broth (Oxoid) for Staphylococci, Streptococcus faecalis and Gram-negative bacteria. The final inoculum was about 104 cfu/ml. MIC was read as the lowest concentration which showed no visible growth after 18~24 hours of incubation at37°C.
Compounds IV Reactions had to be run under a hood and vapors adsorbed by a permanganate solution.
MethodA
General procedure. To a solution of N15-(amino(methylthio)methylene)teicoplanin aglycone hydrochloride7) (Ic, 300 mg, 0.229 mmol) in 15 ml of MeOH, TEA(1 ml) was added and the milky mixture was stirred at 45°C for 6 hours. Solvent was evaporated under vacuum, the residue suspended in water at pH 2 and extracted with a mixture EtOAc -BuOH, 8 : 2 (10 ml). The organic solvent was evaporated and the residue treated with Et2O and filtered, yielding 200 mg of the title compound. Compoundswith unsatisfactory purity were purified by column chromatography as reported in the Experimental section.
Method B THE JOURNAL OF ANTIBIOTICS AUG. 1989 1 6J 7-Didehydro4 6-deoxo4 6-hydroxy-A^^T o a solution of Id hydroiodide (300mg, 0.212 mmol) in 20ml CH3CNand 5 ml water, TEA (2 ml) was added, afterwards the milky mixture was stirred at 40°C for 10 hours, obtaining a complete transformation. Reaction solvent was evaporated under vacuumand the residue, dissolved in CH3CN-water (8 : 2), was purified on 50 g Silica gel RP-8 column eluting with 25 % CH3CNin water, yielding 100 mg.
A^15-Carboxy-1 6, 1 7-didehydro-1 6-deoxo-1 6-methylaminoteicoplanin Aglycone f-Lactam (IVd) Compound Hid was dissolved in MeOHand stirred at 40°C for 6hours. The HPLCanalysis showed the complete transformation of Illd into IVd, confirmed by adding an authentic sample of IVd prepared with Method A.
